CONMED (CNMD) is Upgraded by Ladenburg Thalmann to Buy , according to the research report released to the investors. Earlier the firm had a rating of Neutral on the company shares. The shares recommendation by the Brokerage Firm was released
By clicking this button, you consent to receive emails about new jobs that relate to your search criteria. Remember: you can cancel these email alerts at any time.